Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
Levetiracetam, fosfenytoïne of valproaat bij benzodiazepine-refractaire status epilepticus?
jun 2020 | Epilepsie